The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT

Background: Oxidative stress plays a pivotal role in the pathophysiology of sickle cell disease (SCD) and its associated disease complications. Superoxide Dismutases (SODs) are protective enzymes against oxidative stress. SOD2 deficiency results in the accumulation of oxidized red cell proteins, in...

Full description

Saved in:
Bibliographic Details
Main Authors: Mervat Khorshied, Iman Shaheen, Yasmeen Selim, Asmaa Elshahawy, Ilham Youssry
Format: Article
Language:English
Published: PAGEPress Publications 2022-04-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://www.mjhid.org/index.php/mjhid/article/view/4926
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846144506881114112
author Mervat Khorshied
Iman Shaheen
Yasmeen Selim
Asmaa Elshahawy
Ilham Youssry
author_facet Mervat Khorshied
Iman Shaheen
Yasmeen Selim
Asmaa Elshahawy
Ilham Youssry
author_sort Mervat Khorshied
collection DOAJ
description Background: Oxidative stress plays a pivotal role in the pathophysiology of sickle cell disease (SCD) and its associated disease complications. Superoxide Dismutases (SODs) are protective enzymes against oxidative stress. SOD2 deficiency results in the accumulation of oxidized red cell proteins, increased rate of hemoglobin oxidation, decreased red cell membrane deformability, and subsequently decreased red cells survival. Objective: The current study was designed to determine the effect of SOD2 Val16Ala gene polymorphism (rs4880) on SOD2 level and their possible impact on SCD disease severity in a cohort of Egyptian SCD patients. Methods: Genotyping SOD2 Val16Ala polymorphism by TaqMan allelic discrimination assay for hundred SCD patients and a hundred age-sex matched healthy controls revealed the genotypic and allelic frequencies of the studied polymorphism in the SCD patients were close to that of the controls. Results: Serum SOD2 level was significantly lower in those having the polymorphic genotypes (p=0.005). SOD2 level inversely correlates with the annual rate of hospitalization (r=-0.023, p= 0.038). Conclusion: SOD2 Val16Ala polymorphism was associated with low serum SOD2 levels that may predict disease severity. KEYWORDS. SCD, EGYPT, SOD2, POLYMORPHISM.
format Article
id doaj-art-807e85384cd14a1395fe0819b51b82f1
institution Kabale University
issn 2035-3006
language English
publishDate 2022-04-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-807e85384cd14a1395fe0819b51b82f12024-12-02T07:14:35ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062022-04-0114110.4084/MJHID.2022.037The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT Mervat Khorshied0Iman Shaheen1Yasmeen SelimAsmaa Elshahawy2Ilham Youssry3a:1:{s:5:"en_US";s:9:"Professor";}ProfessorDr.Professor Background: Oxidative stress plays a pivotal role in the pathophysiology of sickle cell disease (SCD) and its associated disease complications. Superoxide Dismutases (SODs) are protective enzymes against oxidative stress. SOD2 deficiency results in the accumulation of oxidized red cell proteins, increased rate of hemoglobin oxidation, decreased red cell membrane deformability, and subsequently decreased red cells survival. Objective: The current study was designed to determine the effect of SOD2 Val16Ala gene polymorphism (rs4880) on SOD2 level and their possible impact on SCD disease severity in a cohort of Egyptian SCD patients. Methods: Genotyping SOD2 Val16Ala polymorphism by TaqMan allelic discrimination assay for hundred SCD patients and a hundred age-sex matched healthy controls revealed the genotypic and allelic frequencies of the studied polymorphism in the SCD patients were close to that of the controls. Results: Serum SOD2 level was significantly lower in those having the polymorphic genotypes (p=0.005). SOD2 level inversely correlates with the annual rate of hospitalization (r=-0.023, p= 0.038). Conclusion: SOD2 Val16Ala polymorphism was associated with low serum SOD2 levels that may predict disease severity. KEYWORDS. SCD, EGYPT, SOD2, POLYMORPHISM. https://www.mjhid.org/index.php/mjhid/article/view/4926SOD2, rs4880, SCD, Egypt
spellingShingle Mervat Khorshied
Iman Shaheen
Yasmeen Selim
Asmaa Elshahawy
Ilham Youssry
The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT
Mediterranean Journal of Hematology and Infectious Diseases
SOD2, rs4880, SCD, Egypt
title The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT
title_full The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT
title_fullStr The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT
title_full_unstemmed The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT
title_short The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT
title_sort impact of superoxide dismutase genetic polymorphism sod2 val16ala and superoxide dismutase level on disease severity in a cohort of egyptian sickle cell disease patients in egypt
topic SOD2, rs4880, SCD, Egypt
url https://www.mjhid.org/index.php/mjhid/article/view/4926
work_keys_str_mv AT mervatkhorshied theimpactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT imanshaheen theimpactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT yasmeenselim theimpactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT asmaaelshahawy theimpactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT ilhamyoussry theimpactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT mervatkhorshied impactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT imanshaheen impactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT yasmeenselim impactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT asmaaelshahawy impactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt
AT ilhamyoussry impactofsuperoxidedismutasegeneticpolymorphismsod2val16alaandsuperoxidedismutaselevelondiseaseseverityinacohortofegyptiansicklecelldiseasepatientsinegypt